Wockhardt touches roof on entering into partnership with UK Government

03 Aug 2020 Evaluate

Wockhard locked its upper circuit limit at Rs. 303.40, up by 27.55 points or 9.99% from its previous closing of Rs. 275.85 on the BSE.

The scrip opened at Rs. 280.00 and has touched a high and low of Rs. 303.40 and Rs. 276.00 respectively. So far 259978 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 411.60 on 11-Feb-2020 and a 52 week low of Rs. 147.20 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 303.40 and Rs. 253.10 respectively. The current market cap of the company is Rs. 3344.20 crore.

The promoters holding in the company stood at 72.13%, while Institutions and Non-Institutions held 4.90% and 22.97% respectively.

Wockhardt has entered into an agreement with the UK Government to fill finish COVID-19 vaccines. The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales.

As per the terms of the agreement the company has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK Government in its fight against COVID19, including AZD1222, the vaccine co-invented by the University of Oxford and its spinout company, Vaccitech and licensed by AstraZeneca.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.

 

Wockhardt Share Price

1341.70 6.00 (0.45%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×